Further evidence to support the melanocytic origin of MDA-MB-435

Journal of Clinical Pathology - Molecular Pathology

Volumn 55, Issue 5, 2002, Pages 294-299

  Ellison, G ^a   Klinowska, T ^a   Westwood, R F R ^a   Docter, E ^a   French, T ^a   Fox, J C ^a  

^a ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CARCINOMA; BREAST CELL; CANCER CELL; CANCER RESEARCH; CELL LINE; CELL STRAIN MDA MB 435; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MELANOCYTE; MELANOMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; BREAST NEOPLASMS; DNA, COMPLEMENTARY; DNA, NEOPLASM; FEMALE; GENE EXPRESSION; GENE LIBRARY; HUMANS; IMMUNOENZYME TECHNIQUES; MELANOCYTES; MELANOMA; MICE; MICE, SCID; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 0036798578     PISSN: 13668714     EISSN: None     Source Type: Journal    
DOI: 10.1136/mp.55.5.294     Document Type: Article

References (18)

1. Cailleau R, Olive M, Cruciger QV. Long-term human breast carcinoma cell lines of metastatic origin: preliminary characterization. In Vitro 1978;14:911-15.
2. Meiners S, Brinkmann V, Naundorf H, et al. Role of morphogenetic factors in metastasis of mammary carcinoma cells. Oncogene 1998;16:9-20.
3. Ross DT, Scherf U, Eisen MB, et al. Systematic variation in gene expression patterns in human cancer cell lines. Nat Genet 2000;24:227-35.
4. Xin H, Stephans JC, Duan XZ, et al. Identification of a novel aspartic-like protease differentially expressed in human breast cancer cell lines. Biochim Biophys Acta 2000;1501:125-37.
5. Perlino E, Tommasi S, Moro L, et al. TGF-beta 1 and IGF-1 expression are differently regulated by serum in metastatic and non-metastatic human breast cancer cells. Int J Oncol 2000;16:155-60.
6. Hurst DR, Li H, Xu XY, et al. Development and characterization of a new polyclonal antibody specifically against tissue inhibitor of metalloproteinases 4 in human breast cancer. Biochem Biophys Res Commun 2001;281:166-71.
7. Huang LL, Pardee AB. Suberoylanilide hydroxamic acid as a potential therapeutic agent for human breast cancer treatment. Mol Med 2000;6:849-66.
8. Bemis LT, Schedin P. Reproductive state of rat mammary gland stroma modulates human breast cancer cell migration and invasion. Cancer Res 2000;60:3414-18.
9. Hanby AM, Poulsom R, Singh S, et al. Spasmolytic polypeptide and pS2 in the stomach. Gastroenterology 1993;105:1110-16.
10. Watson MA, Fleming TP. Mammaglobin, a mammary specific member of the uteroglobin gene family, is overexpressed in human breast cancer. Cancer Res 1996;56:860-5.
11. Murphy LC, Tsuyuki D, Myal Y, et al. Isolation and sequencing of a cDNA clone for a prolactin-inducible RT protein (PIP). Regulation of PIP gene expression in the human breast RT cancer ceil line, T-47D. J Biol Chem 1987;262:15236-41.
12. Mangelsdorf DJ, Borgmeyer U, Heyman RA, et al. Characterization of three RXR genes that mediate the action of 9-cis retinoic acid. Genes Dev 1992;6:329-44.
13. Lord DK, Cross NCP, Bevilacqua MA, et al. Type 5 acid phosphatase. Sequence, expression and chromosomal localization of a differentiation-associated protein of the human macrophage. Eur J Biochem 1990;189:287-93.
14. Giebel LB, Strunk KM, Spritz RA. Organization and nucleotide sequences of the human tyrosinase gene and a truncated tyrosinase-related segment. Genomics 1991;9:435-45.
15. Bouchard B, del Marmol V, Jackson U, et al. Molecular characterization of a human tyrosinase-related-protein-2 cDNA. Patterns of expression in melanocytic cells. Eur J Biochem 1994;219:127-34.
16. Boyce BF, Yoneda T, Guise TA, Factors regulating the growth of metastatic cancer in bone. Endocr Relat Cancer 1999;6:333-47.
17. Mayer B, Lorenz C, Babic R, et al. Expression of leukocyte cell adhesion molecules on gastric carcinomas-possible involvement of LFA-3 expression in the development of distant metastases. Int J Cancer 1995;64:415-23.
18. Fedarko NS, Fohr B, Robey PG, et al. Factor H binding to bone sialoprotein and osteopontin enables tumor cell evasion of complement-mediated attack. J Biol Chem 2000;275:16666-72.